Abstract:Objective: To evaluate the efficacy and safety of injectable gatifloxacin. Methods; In this multicenter, single-blind, randomized comparative study, patients with infection of lower respiratory tract and urinary tract were allocated randomly to gatifloxacin group or levofloxacin group. In each group patients were given gatifloxacin or levofloxacin intrevenously for 3-5 d followed by oral formulation. Results: (1)The clinical effective rates (gatifloxacin vs. levofloxacin) were 92.4%(110/119) vs. 91.2%(114/ 125), being 94.296(65/69) vs. 90.296(65/72) for lower respiratory tract infections and 90.0% (45/50) vs. 92.5%(42/72) for urinary tract infections, respectively, there was no statistically significant difference between the two groups; (2)The total bacterial eradication rates were 94.0% (78/83) vs. 88.0% (81/92), being 89.2% (33/37) vs. 92.9% (39/42) for urinary tract infections, there was no statistically significant difference between the two groups; however, the bacterial eradication rate of gatifloxacin (97.8% , 45/46) was higher than that of levofloxacin (84. 3% , 43/51) in lower respiratory tract infections, the difference was statistically significant. (3)Drug-related adverse effects were 29.9% (38/127) in gatifloxacin group, higher than that in levofloxacin group 10.1% (13/129). This is due to more patients with phlebitis and gastrointestinal symptoms in gatifloxacin group than those in levofloxacin group. These drug-related events could be alleviated by slowing down the speed of infusion; the adverse effects of both groups were mild and tolerable, no discontinuation of treatment due to adverse reaction. Drug-related abnormal laboratory findings oc- carred in gatifloxacin group and levefloxacin group were 24. 8% (30 /121) and 22. 1 % (27 /112) respectively. All were mild and transient, and there was no statistically significant difference between the two groups. Conclusions: Gatifloxacin given intravenously used as initial therapy in infectious patients with systemic clinical manifestations and followed by oral administration for the completion of therapy may get satisfactory results. The clinical efficacy of gatifloxacin is as good as that of levofloxacin. The adverse reaction rate of gatifloxacin was slightly higher than that of levofloxacin, but all the reactions are mild and tolerable.

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis

Safety and Efficacy of Levofloxacin Versus Ciprofloxacin for the Treatment of Chronic Bacterial Prostatitis in Chinese Patients

A Randomized Controlled Clinical Study on Levofloxacin Versus Ciprofloxacin in the Treatment of Bacterial Infections

Effect of mercifloxacin and levofloxacin on urinary tract infection

Clinical evaluation of levofloxacin sequential therapy in the treatment of 214 patients with bacterial infections

A Double-Blind, Randomized Controlled Clinical Study:Gatifloxacin Vs Levofloxacin in Treatment of 98 Patients with Urinary Tract Infections

Urinary Tract Infections: Epidemiology, Mechanisms of Infection, and Treatment

The clinical efficacy and safety evaluation of cefazolin sodium combined with levofloxacin for acute urinary tract infection

Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis

Randomized-controlled Clinical Trial on Fosfomycin Trometamal Versus Ciprofloxacin in the Treatment of Urological Tract Bacterial Infections

Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Adults with Bacterial Infections: A Double-Blind, Randomized Trial in China

A Randomized, Patient-Blind, Multicenter Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Lower Respiratory Tract Infections and Urinary Tract Infections

A randomized comparative study of gatifloxacin and ciprofloxacin in the treatment of bacterial infections

Clinical evaluation of pazufloxacin and levofloxacin in the treatment of bacterial infections

Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients: an analysis of national representative claims database

Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: Combined retrospective analyses of two real-world databases and in vitro data.

A Randomized,controlled Clinical Trial of Levofloxacin Versus Ceftriaxone and Azithromycin in the Treatment of Community-Acquired Lower Respiratory Tract Infections

A Multicenter, Single-Blind, Randomized Comparison of Sequential Therapy of Gatifloxacin Versus Levofloxacin in the Treatment of Bacterial Infections

Fleroxacin Vs Ciprofloxacin in Treatment of Bacterial Infection

Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers

Cost-effectiveness Analysis of Levofloxacin and Gatifoxacin in the Treatment of Lower Respiratory Tract Infections